The West Africa Biomanufacturing Regulation and Market Access Forum was held on 24-25 March 2026 in Accra, Ghana.

As part of Bio Usawa's engagement at the West Africa Biomanufacturing Regulation & Market Access Forum in Ghana last week, our Head of Global Regulatory Strategy, Eric Karikari-Boateng, represented the company on the regulatory front.

Karikari-Boateng engaged with key leaders and conversations shaping the future of regulatory systems for vaccines and biologics across Africa; particularly around harmonization, market access, and the role of continental institutions in enabling efficient approval pathways.

Reflecting on the forum, he noted:“What stood out was the growing shift from alignment in principle to alignment in practice. The opportunity now is to ensure regulatory systems evolve at the same pace as Africa’s manufacturing ambitions.”

The forum also created space to reconnect with long-standing regulatory leadership, including H.E. Delese Mimi Darko — formerly his colleague at the Ghana FDA and now Director General of the African Medicines Agency — highlighting the continuity between national regulatory experience and emerging continental coordination.

At Bio Usawa, we recognize that regulatory alignment and collaboration will be critical to unlocking the full potential of Africa’s biomanufacturing ecosystem. Engagements like this ensure we remain closely connected to the evolving landscape and contribute thoughtfully to its development.

Eric Karikari-Boateng, Bio Usawa's Head of Global Regulatory Strategy, speaks at the West Africa Biomanufacturing Regulation and Market Access Forum in Accra, Ghana, on 24 March 2026.

Karikari-Boateng (R), Bio Usawa's Head of Global Regulatory Strategy, with H.E. Delese Mimi Darko, Director General of the African Medicines Agency at the forum.